Many people start learning about IVF by hearing terms like “day-3 embryos,” “day-5 transfer,” or “blastocyst.” It can feel like a new language when you’re already juggling appointments, injections, and hope.

Blastocyst culture is simply a way of growing embryos in the lab for a little longer, usually to day 5 or day 6 after fertilisation, so the embryology team can see which ones continue to develop well. This extra time helps with selection and often allows doctors to transfer just one strong embryo while keeping the chance of pregnancy high and the risk of twins low.

Not every patient needs it, and not every IVF cycle is suited to it, but for many, it’s become a standard part of modern IVF because it improves decision-making at transfer.

Blastocyst culture means keeping embryos in the lab until they reach the “blastocyst” stage, usually on day 5 or 6, instead of transferring them earlier on day 2 or 3. At this point the embryo has hundreds of cells and two clear parts: the inner cell mass (which becomes the fetus) and the trophectoderm (which becomes the placenta).

Growing embryos to this stage uses specialised culture media, stable temperature and pH control, and careful observation. The goal is simple: identify embryos that show ongoing growth and organisation, because those are more likely to implant after transfer. PMC

Embryos are placed in drops of culture media and kept in small, controlled incubators that hold temperature and gases steady.

Embryologists check development at planned intervals, looking for cell division patterns on day 2 and day 3 and then for a fluid-filled cavity and a well-formed inner cell mass by day 5 or 6.

Some clinics use time-lapse systems so embryos can be observed without removing them from the incubator. When a blastocyst looks ready, it can be transferred fresh or frozen for a future cycle.

Why do Clinics Use Blastocyst Culture?

On day 2 or 3 (the “cleavage” stage), embryos have only a handful of cells, so it is harder to tell which ones will keep going. On day 5 or 6, a blastocyst has expanded, started to form a cavity, and shows clearer structure. That visible progress helps with selection and often translates into better implantation per transfer.

However, there is a trade-off: by waiting until day 5/6, some embryos stop growing in the lab, which can reduce how many you have available overall. This is why your team will balance embryo numbers, your age, egg quality, and your history when choosing between day-3 and day-5 plans.

Per fresh transfer, many studies show a higher chance of ongoing pregnancy or live birth with a single blastocyst compared with a single cleavage-stage embryo. A recent review summarised that fresh blastocyst transfers may lead to more live births than fresh cleavage-stage transfers.

That said, because fewer embryos may reach day 5/6, the cumulative chance of a baby from one egg collection (counting fresh and all frozen transfers) can be similar between the two strategies for some patients. This is why the decision is personalised rather than automatic.

Yes, by supporting single-embryo transfer (SET) without reducing success for many patients.

Professional guidelines encourage SET in suitable cases, and they specifically state that when a chromosomally normal (euploid) embryo is available, only one should be transferred regardless of age.

Reducing the number of embryos transferred is the most effective way to avoid twins, which carry higher health risks for both the pregnant person and the babies.

There are several advantages of Blastocyst Culture:

• Sharper embryo selection
  Letting embryos reach day 5/6 helps spot the ones that keep developing well, which usually boosts implantation per transfer.
• Better timing with the uterus
  A day-5 transfer lines up more closely with when an embryo naturally reaches the uterus, improving endometrium–embryo sync.
• Supports single-embryo transfer
  Because selection is stronger, clinics can transfer one good blastocyst and still keep success high by cutting twin/triplet risk.
• PGT-friendly
  The blastocyst stage is ideal for biopsy (a few trophectoderm cells), so genetic testing slots neatly into the workflow.

The main downside is that some cycles may end with few or no blastocysts to transfer, especially when egg numbers are low. Waiting until day 5/6 means some embryos are arrested before transfer, and in a small share of cycles, there may be nothing suitable to move or freeze.

A few studies have also suggested slightly different perinatal patterns after blastocyst transfer (for example, preterm birth) compared with cleavage-stage transfer, though findings are mixed and still being studied. Your doctor will weigh these factors against the potential gains in selection.

People with a reasonable number of good-quality embryos on day 3 often benefit most from extending culture to day 5/6. In such cases, the chance of having blastocysts to choose from is higher, which makes selection and SET practical. This approach is very common worldwide and is supported by both professional societies and national regulators.

Who Might be Advised to Transfer Earlier?

In these situations, the uterus provides the natural environment while the embryos continue to grow inside the body.

Your team will explain the pros and cons in your specific case, including your age, egg quality, and any previous cycle outcomes.

Many clinics now freeze (vitrify) blastocysts and transfer in a later cycle because it can simplify timing and allow the endometrium to be prepared calmly. Others still perform fresh transfers when hormone levels and lining look good.

Survival after vitrification is high in modern programs, and some centres will thaw day-3 embryos and grow them to day 5 before transfer in frozen cycles when that improves selection. Your clinic will choose the sequence that best fits your medical picture and lab practice.

Not directly, but it helps identify embryos with better developmental potential, which often correlates with chromosomal normality. True chromosome screening requires preimplantation genetic testing (PGT).

If PGT is part of your plan, biopsy is usually done at the blastocyst stage from the trophectoderm, and professional groups publish guidance on how to interpret those results (including “mosaic” findings).

Professional guidance is clear: transfer one embryo in most cases; transfer of more than one is generally reserved for specific situations after careful counselling. If genetic testing shows a euploid blastocyst, guidance recommends transferring one regardless of age. The aim is to maintain success while avoiding the extra risks tied to multiple pregnancy.